Page 1

X OrganoClick INTERIM REPORT JANUARY - MARCH 2021 CORPORATE IDENTITY NUMBER : 556704-6908 JANUARY TO MARCH Net sales SEK 29,656 ( 22,248 ) thousands Revenue growth 33.3 ( 0.4 ) percent EBITDA SEK -839 ( -1,368 ) thousand Cash flow from operating activites SEK -18,192 ( -3,284 ) thousand Earnings per share before and after dilution SEK -0.07 ( -0.06 ) OrganoClick signed a 5 - year framework agreement with a leading nonwoven manufacturer for supply of OrganoClick's biobased binders with an estimated sales value around SEK 30 million per year . KEY RATIOS ( for definitions , please refer to page 19 ) Jan - Mar 2021 Net sales 29,656 EBIT -4,563 -18,192 Cash flow from operating activities Gross margin after variable costs , % 42.3 OPEN Jan - Mar 2020 22,248 -4,462 -3,284 43.1 LTM 31 Mar 2021 103,865 -17,200 -9,437 41.6 Jan - Dec 2020 96,458 -17,100 5,471 41.8